A useful topical TRT comparison starts with the prescription and the household routine. The cheapest cream offer does not tell you whether the product fits your diagnosis, whether an approved alternative is appropriate, or how to manage contact with a partner or child.
This remains a question-led shortlist with non-CoreAge information checked September 23, 2026. The September 27 CoreAge check found an injectable product page marked Coming soon. CoreAge has promotional first placement, but no testosterone cream or gel offer was verified.
KEEP IN MIND
The useful bits.
- CoreAge has disclosed promotional first placement; its injectable listing currently says Coming soon.
- Ask for the topical product’s own instructions and price.
- Household contact and monitoring belong in the consultation.
The comparison list
Number 1 is publisher-selected promotion. These positions do not measure clinical outcomes.
PROMOTIONAL FIRST PLACEMENT
CoreAge Rx
Publisher-selected promotion. Injectable TRT page found; Coming soon still displayed. Confirm opening, full costs, and pharmacy.
Advertised from $129/month; Coming soon
PROVIDER TO COMPARE
Fountain TRT
Lists topical cream; confirm exact prescription, pharmacy, and contact precautions.
$199 / 4 weeks; longer commitments available
PROVIDER TO COMPARE
Maximus
Lists topical options; obtain a topical-specific quote and instructions.
Topical quote required
What earns a place in this comparison
We looked for information that can support a discussion about topical treatment: a visible treatment menu, a clinical assessment pathway, or a useful contrast in how care is organized. We did not test the services or compare patient outcomes. Inclusion does not mean that a clinic will prescribe a topical medicine for you.
An adequate answer names the product and pharmacy, explains its approval status, and gives instructions for monitoring and skin contact. It should also make room for an alternative when a topical routine does not fit your circumstances. Our cream versus gel guide provides the product questions behind this shortlist.
Sources: DailyMed: AndroGel 1.62% prescribing information · FDA: understanding the risks of compounded drugs · Endocrine Society: testosterone therapy clinical guidance
CoreAge Rx: the verified listing is injectable
The CoreAge TRT page now names compounded testosterone cypionate for injection and advertises a starting price of $129 per month. It does not establish a topical testosterone product. This is an important route limitation for a reader researching cream or gel, regardless of CoreAge’s featured position.
Read the CoreAge review and confirm current access before considering care. If a different route is proposed directly, request its full product details and instructions. The promotion should not be read as a recommendation to choose injections instead of a topical medicine or as evidence of a currently available topical service.
Sources: CoreAge Rx: injectable TRT product page and Coming soon status · CoreAge Rx: general service, billing, and pharmacy FAQ · CoreAge Rx: refund, subscription, and shipping policy
Fountain: ask which cream and which billing period
Fountain explicitly lists topical testosterone cream among its possible treatment options. That makes the prescription details worth investigating, but does not establish a particular product’s approval status or individual suitability. Ask for the exact formulation, pharmacy, contact precautions, and reason for selecting it.
Its week-based prices need a separate budget discussion. The $199 Starter rate covers four weeks; longer plans cover 12 or 48 weeks. The Fountain review explains the calendar issue and the questions surrounding testing upgrades. Compare the quoted care period as carefully as the medicine.
Sources: Fountain: TRT options and four-week, 12-week, and 48-week billing
Turn the shortlist into an appointment checklist
Bring a description of your daily routine, current medicines, prior results, and regular skin contact with other people. Ask how exposure precautions work for the proposed product, how follow-up testing is timed, and how to reach a clinician about side effects. Blood-pressure and other monitoring questions remain relevant with a topical route.
Use the medication-route comparison if injections or oral treatment also interest you. The goal is not to secure a cream at any cost. It is to understand whether treatment is indicated and, if so, whether the prescribed product, household precautions, follow-up, and payment terms make a workable plan.
Sources: DailyMed: AndroGel 1.62% prescribing information · Endocrine Society: testosterone therapy clinical guidance · FDA: 2025 testosterone labeling and blood pressure changes
Sources you can check
Provider pages describe commercial offers. Medical references provide context. Source review: September 23, 2026. CoreAge details rechecked September 27, 2026. Prices and availability can change.
- DailyMed: AndroGel 1.62% prescribing information
- FDA: understanding the risks of compounded drugs
- Endocrine Society: testosterone therapy clinical guidance
- CoreAge Rx: injectable TRT product page and Coming soon status
- CoreAge Rx: general service, billing, and pharmacy FAQ
- CoreAge Rx: refund, subscription, and shipping policy
- Fountain: TRT options and four-week, 12-week, and 48-week billing
- Maximus: testosterone treatment options
- Maximus: compounded oral testosterone, plan prices, and laboratory requirements
- FDA: 2025 testosterone labeling and blood pressure changes
A FREE TAKE-HOME FROM THE DESK
Before you commit,
put it on paper.
Get the TRT Decision Kit: a first-year cost worksheet, 12 questions to ask a clinic, and a checklist for reading the fine print.
Free for every subscriber. Educational resources, with five short daily emails to help you use them. No purchase needed.
See what’s in the kit ↗Form not loading? Open the signup form. Privacy & email preferences.
Educational information for adults, not a diagnosis or treatment plan. Discuss symptoms and treatment decisions with a licensed clinician. Do not change a prescription based on this article.